Patents Assigned to Instituto Nacional De Ciencias Medicas y Nutricion
  • Inhibiting inflammation with milk oligosaccharides
    Patent number: 12171773
    Abstract: A method of inhibiting inflammation with milk oligosaccharides or glycoconjugates containing the oligosaccharides.
    Type: Grant
    Filed: May 4, 2022
    Date of Patent: December 24, 2024
    Assignees: Children's Hospital Medical Center, The General Hospital Corporation, Instituto Nacional de Ciencias. Medicas Y Nutricion
    Inventors: Ardythe L. Morrow, David S. Newburg, Guillermo M. Ruiz-Palacios
  • INHIBITING INFLAMMATION WITH MILK OLIGOSACCHARIDES
    Publication number: 20230101412
    Abstract: A method of inhibiting inflammation with milk oligosaccharides or glycoconjugates containing the oligosaccharides.
    Type: Application
    Filed: May 4, 2022
    Publication date: March 30, 2023
    Applicants: Children's Hospital Medical Center, The General Hospital Corporation d/b/a Massachusetts General Hospital, Instituto Nacional de Ciencias Medicas Y Nutricion
    Inventors: Ardythe L. Morrow, David S. Newburg, Guillermo M. Ruiz-Palacios
  • Inhibiting inflammation with milk oligosaccharides
    Patent number: 11324765
    Abstract: A method of inhibiting inflammation with milk oligosaccharides or glycoconjugates containing the oligosaccharides.
    Type: Grant
    Filed: May 28, 2021
    Date of Patent: May 10, 2022
    Assignees: Children's Hospital Medical Center, The General Hospital Corporation, Instituto Nacional de Ciencias Medicas Y Nutricion
    Inventors: Ardythe L. Morrow, David S. Newburg, Guillermo M. Ruiz-Palacios
  • INHIBITING INFLAMMATION WITH MILK OLIGOSACCHARIDES
    Publication number: 20210283155
    Abstract: A method of inhibiting inflammation with milk oligosaccharides or glycoconjugates containing the oligosaccharides.
    Type: Application
    Filed: May 28, 2021
    Publication date: September 16, 2021
    Applicants: Children's Hospital Medical Center, The General Hospital Corporation d/b/a Massachusetts General Hospital, Instituto Nacional de Ciencias Medicas Y Nutricion
    Inventors: Ardythe L. Morrow, David S. Newburg, Guillermo M. Ruiz-Palacios
  • Inhibiting inflammation with milk oligosaccharides
    Patent number: 11058697
    Abstract: A method of inhibiting inflammation with milk oligosaccharides or glycoconjugates containing the oligosaccharides.
    Type: Grant
    Filed: August 16, 2018
    Date of Patent: July 13, 2021
    Assignees: CHILDREN'S HOSPITAL MEDICAL CENTER, INSTITUTO NACIONAL DE CIENCIAS MEDICAS Y NUTRICION, THE GENERAL HOSPITAL CORPORATION
    Inventors: Ardythe L. Morrow, David S. Newburg, Guillermo M. Ruiz-Palacios
  • Inhibiting inflammation with milk oligosaccharides
    Publication number: 20190099435
    Abstract: A method of inhibiting inflammation with milk oligosaccharides or glycoconjugates containing the oligosaccharides.
    Type: Application
    Filed: August 16, 2018
    Publication date: April 4, 2019
    Applicants: Children's Hospital Medical Center, The General Hospital Corporation d/b/a Massachusetts General Hospital, Instituto Nacional de Ciencias Medicas Y Nutricion
    Inventors: Ardythe L. Morrow, David S. Newburg, Guillermo M. Ruiz-Palacios
  • AGAVACEAE EXTRACT COMPRISING STEROIDAL SAPONINS TO TREAT OR PREVENT METABOLIC DISORDER RELATED PATHOLOGIES
    Publication number: 20190060341
    Abstract: A saponin and sapogenin extract recovered from plants of the Agavaceae family in the form of an extract or its purified form which has beneficial effects on the organism of mammals in relation to the prevention or treatment of metabolic disorders such as obesity, metabolic syndrome, diabetes and their related pathologies in mammals, including humans and further beneficial effects on lipid metabolism, glucose metabolism, energy expenditure, and gut microbiota health. Other aspects of the invention comprise a composition made of said saponin and sapogenin extract and methods for using said extract.
    Type: Application
    Filed: October 16, 2015
    Publication date: February 28, 2019
    Applicants: INSTITUTO TECNOLÓGICO Y DE ESTUDIOS SUPERIORES DE MONTERREY, INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN, AGMEL S.A. DE C.V.
    Inventors: Ana María LEAL DÍAZ, Janet Alejandra GUTIÉRREZ URIBE, Nimbe TORRES Y TORRES, Armando Roberto TOVAR PALACIO, Lilia Guadalupe NORIEGA LÓPEZ
  • Inhibiting inflammation with milk oligosaccharides
    Patent number: 10098903
    Abstract: A method of inhibiting inflammation with milk oligosaccharides or glycoconjugates containing the oligosaccharides.
    Type: Grant
    Filed: April 30, 2015
    Date of Patent: October 16, 2018
    Assignees: Children's Hospital Medical Center, The General Hospital Corporation, Instituto Nacional de Ciencias Medicas Y Nutricion
    Inventors: Ardythe L. Morrow, David S. Newburg, Guillermo M. Ruiz-Palacios
  • INHIBITING INFLAMMATION WITH MILK OLIGOSACCHARIDES
    Publication number: 20150306120
    Abstract: A method of inhibiting inflammation with milk oligosaccharides or glycoconjugates containing the oligosaccharides.
    Type: Application
    Filed: April 30, 2015
    Publication date: October 29, 2015
    Applicants: Children's Hospital Medical Center, The General Hospital Corporation, Instituto Nacional de Ciencias Medicas Y Nutricion
    Inventors: Ardythe L. Morrow, David S. Newburg, Guillermo M. Ruiz-Palacios
  • Use of secretor, Lewis and sialyl antigen levels in clinical samples as predictors of risk for disease
    Patent number: 9132142
    Abstract: An individual at risk for necrotizing enterocolitis and related disorders can be identified by measuring the level of at least one secretor antigen in a biological sample from the individual and comparing the measured level of the at least one secretor antigen to a predetermined value or a predetermined range of values. Among the secretor antigens which can be measured are: the H-1, H-2, Lewisb and Lewisy antigens and derivatives thereof (e.g., a sialylated form of Lewis a, Lewis x, Lewis b, Lewis y; H-1, H-2, Lewis a, Lewis x, Lewis b or Lewis y).
    Type: Grant
    Filed: October 2, 2013
    Date of Patent: September 15, 2015
    Assignees: The General Hospital Corporation, Instituto Nacional de Ciencias Medicas Y Nutricion, Children's Hospital Medical Center
    Inventors: Ardythe L. Morrow, David S. Newburg, Guillermo M. Ruiz-Palacios
  • Use of secretor, lewis and sialyl antigen levels in clinical samples as predictors of risk for disease
    Patent number: 9132143
    Abstract: An individual at risk for necrotizing enterocolitis and related disorders can be identified by measuring the level of at least one secretor antigen in a biological sample from the individual and comparing the measured level of the at least one secretor antigen to a predetermined value or a predetermined range of values. Among the secretor antigens which can be measured are: the H-1, H-2, Lewisb and Lewisy antigens and derivatives thereof (e.g., a sialylated form of Lewis a, Lewis x, Lewis b, Lewis y; H-1, H-2, Lewis a, Lewis x, Lewis b or Lewis y).
    Type: Grant
    Filed: September 23, 2014
    Date of Patent: September 15, 2015
    Assignees: The General Hospital Corporation, Instituto Nacional de Ciencias Medicas Y Nutricion, Children's Hospital Medical Care
    Inventors: Ardythe L. Morrow, David S. Newburg, Guillermo M. Ruiz-Palacios
  • Inhibiting inflammation with milk oligosaccharides
    Patent number: 9034847
    Abstract: A method of inhibiting inflammation in a subject comprising the administration of milk oligosaccharides or glycoconjugates containing milk oligosaccharides is disclosed.
    Type: Grant
    Filed: July 2, 2010
    Date of Patent: May 19, 2015
    Assignees: Children's Hospital Medical Center, The General Hospital Corporation, Instituto Nacional de Ciencias Medicas Y Nutricion
    Inventors: Ardythe L. Morrow, David S. Newburg, Guillermo M. Ruiz-Palacios
  • USE OF SECRETOR, LEWIS AND SIALYL ANTIGEN LEVELS IN CLINICAL SAMPLES AS PREDICTORS OF RISK FOR DISEASE
    Publication number: 20150079055
    Abstract: An individual at risk for necrotizing enterocolitis and related disorders can be identified by measuring the level of at least one secretor antigen in a biological sample from the individual and comparing the measured level of the at least one secretor antigen to a predetermined value or a predetermined range of values. Among the secretor antigens which can be measured are: the H-1, H-2, Lewisb and Lewisy antigens and derivatives thereof (e.g., a sialylated form of Lewis a, Lewis x, Lewis b, Lewis y; H-1, H-2, Lewis a, Lewis x, Lewis b or Lewis y).
    Type: Application
    Filed: September 23, 2014
    Publication date: March 19, 2015
    Applicants: Children's Hospital Medical Center, The General Hospital Corporation, Instituto Nacional de Ciencias Medicas Y Nutricion
    Inventors: Ardythe L. Morrow, David S. Newburg, Guillermo M. Ruiz-Palacios
  • Use of Secretor, Lewis and Sialyl Antigen Levels in Clinical Samples as Predictors of Risk for Disease
    Publication number: 20140140970
    Abstract: An individual at risk for necrotizing enterocolitis and related disorders can be identified by measuring the level of at least one secretor antigen in a biological sample from the individual and comparing the measured level of the at least one secretor antigen to a predetermined value or a predetermined range of values. Among the secretor antigens which can be measured are: the H-1, H-2, Lewisb and Lewisy antigens and derivatives thereof (e.g., a sialylated form of Lewis a, Lewis x, Lewis b, Lewis y; H-1, H-2, Lewis a, Lewis x, Lewis b or Lewis y).
    Type: Application
    Filed: October 2, 2013
    Publication date: May 22, 2014
    Applicants: Children's Hospital Medical Center, Instituto Nacional de Ciencias Medicas Y Nutricion, The General Hospital Corporation
    Inventors: Ardythe L. Morrow, David S. Newburg, Guillermo M. Ruiz-Palacios
  • Use of secretor, lewis and sialyl antigen levels in clinical samples as predictors of risk for disease
    Patent number: 8574850
    Abstract: An individual at risk for necrotizing enterocolitis and related disorders can be identified by measuring the level of at least one secretor antigen in a biological sample from the individual and comparing the measured level of the at least one secretor antigen to a predetermined value or a predetermined range of values. Among the secretor antigens which can be measured are: the H-1, H-2, Lewisb and Lewisy antigens and derivatives thereof (e.g., a sialylated form of Lewis a, Lewis x, Lewis b, Lewis y; H-1, H-2, Lewis a, Lewis x, Lewis b or Lewis y).
    Type: Grant
    Filed: January 14, 2011
    Date of Patent: November 5, 2013
    Assignees: Instituto Nacional de Ciencias Medicas Y Nutricion, The General Hospital Corporation, Children's Hospital Medical Center
    Inventors: Ardythe L. Morrow, Guillermo Ruiz-Palacios, David S. Newburg
  • INHIBITING INFLAMMATION WITH MILK OLIGOSACCHARIDES
    Publication number: 20120202753
    Abstract: A method of inhibiting inflammation in a subject comprising the administration of milk oligosaccharides or glycoconjugates containing milk oligosaccharides is disclosed.
    Type: Application
    Filed: July 2, 2010
    Publication date: August 9, 2012
    Applicants: Instituto Nacional de Ciencias Medicas Y Nutricion, The General Hospital Corporation d/b/a Massachusetts General Hospital, (CCHMC)
    Inventors: Ardythe L. Morrow, David S. Newburg, Guillermo M. Ruiz-Palacios
  • OLIGOSACCHARIDE COMPOSITIONS AND USE THEREOF IN THE TREATMENT OF INFECTION
    Publication number: 20110207659
    Abstract: Oligosaccharides and oligosaccharides linked to backbones such as proteins, methods for making such oligosaccharides and methods for using them to treat and/or prevent various disorders are described.
    Type: Application
    Filed: February 22, 2011
    Publication date: August 25, 2011
    Applicants: Children's Hospital Medical Center, University of Massachusetts, Instituto Nacional de Ciencias Medicas Y Nutricion
    Inventors: Ardythe L. Morrow, David S. Newburg, Guillermo M. Ruiz-Palacios
  • Oligosaccharide compositions and use thereof in the treatment of infection
    Patent number: 7893041
    Abstract: Oligosaccharides and oligosaccharides linked to backbones such as proteins, methods for making such oligosaccharides and methods for using them to treat and/or prevent various disorders are described.
    Type: Grant
    Filed: December 6, 2004
    Date of Patent: February 22, 2011
    Assignees: Children's Hospital Medical Center, Instituto Nacional De Ciencias Medicas Y Nutricion, University of Massachusetts
    Inventors: Ardythe L. Morrow, David S. Newburg, Guillermo M. Ruiz-Palacios
  • Use of secretor, Lewis and sialyl antigen levels in clinical samples as predictors of risk for disease
    Patent number: 7871785
    Abstract: An individual at risk for necrotizing enterocolitis and related disorders can be identified by measuring the level of at least one secretor antigen in a biological sample from the individual and comparing the measured level of the at least one secretor antigen to a predetermined value or a predetermined range of values. Among the secretor antigens which can be measured are: the H-1 , H-2, Lewisb and Lewisy antigens and derivatives thereof (e.g., a sialylated form of Lewis a, Lewis x, Lewis b, Lewis y; H-1, H-2, Lewis a, Lewis x, Lewis b or Lewis y).
    Type: Grant
    Filed: September 5, 2008
    Date of Patent: January 18, 2011
    Assignees: Children's Hospital Medical Center, The General Hospital Corporation, Instituto Nacional De Ciencias Medicas y Nutricion
    Inventors: Ardythe L. Morrow, Guillermo M. Ruiz-Palacios, David S. Newburg